NCT00619866View on ClinicalTrials.gov

An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

PHASE2CompletedINTERVENTIONAL

Enrollment

155

Participants

Timeline

Start Date

February 19, 2008

Primary Completion Date

April 20, 2009

Study Completion Date

August 28, 2009

Conditions

Endometriosis, Pain

Interventions

DRUG

Elagolix

Elagolix tablets administered orally

DRUG

placebo

Placebo tablet administered orally

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY